Literature DB >> 8071534

Detection and quantification of hepatitis C virus RNA replication in the liver.

N Sakamoto1, N Enomoto, M Kurosaki, F Marumo, C Sato.   

Abstract

To investigate the correlation between the replication of hepatitis C virus in liver and the clinical and histopathological features, we detected and quantified plus and minus strands of HCV-RNA in plasma and in livers of patients with chronic hepatitis C by a quantitative polymerase chain reaction. RNA was extracted from the plasma and liver tissue of ten patients with biopsy-proven chronic hepatitis C. The plus and minus strands of HCV-RNA were detected by a strand-specific reverse transcription with either sense or anti-sense oligonucleotide primers deduced from the hepatitis C virus genome, and a standard HCV-RNA with an enzyme restriction site was used to quantify the amount of HCV-RNA. Both plus and minus strands of HCV-RNA were detected from the liver tissue of all patients included. The amount of plus-stranded HCV-RNA in the liver was 10 times higher than that of minus-stranded HCV-RNA. Plus-stranded HCV-RNA was detected in the plasma in all patients, while the minus strand was not detected in any patient. There was a weak correlation between the amount of both strands of HCV-RNA in the liver and that of the plus strand in plasma. There was no significant correlation between the amount of liver HCV-RNA and serum alanine transaminase and aspartate transaminase levels, or histopathological findings in the liver. The present method of detecting and quantifying liver HCV-RNA is simple and sensitive; it may be used to detect residual hepatitis C virus replication after the disappearance of plasma HCV-RNA in acute hepatitis or in chronic hepatitis after interferon treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8071534     DOI: 10.1016/s0168-8278(05)80345-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection.

Authors:  P H McGuinness; D Painter; S Davies; G W McCaughan
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

2.  Quantification of hepatitis C virus (HCV) in liver specimens and sera from patients with human immunodeficiency virus coinfection by using the Versant HCV RNA 3.0 (branched DNA-based) DNA assay.

Authors:  Rosamaria Tedeschi; Eliana Pivetta; Stefania Zanussi; Ettore Bidoli; Mirna Ros; Giampiero di Gennaro; Guglielmo Nasti; Paolo De Paoli
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

3.  Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection.

Authors:  G H Haydon; L M Jarvis; C S Blair; P Simmonds; D J Harrison; K J Simpson; P C Hayes
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

4.  Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features.

Authors:  L De Moliner; P Pontisso; G L De Salvo; L Cavalletto; L Chemello; A Alberti
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

Review 5.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

6.  Characterization of the genome and structural proteins of hepatitis C virus resolved from infected human liver.

Authors:  Søren U Nielsen; Margaret F Bassendine; Alastair D Burt; Debra J Bevitt; Geoffrey L Toms
Journal:  J Gen Virol       Date:  2004-06       Impact factor: 3.891

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.